Biochemical Test and Species Identification of Haemophilus influenzae
Haemophilus influenzae is a significant human pathogen, a small, fastidious, Gram-negative coccobacillus that is responsible for a range of infections, from serious invasive diseases like meningitis and septicemia to non-invasive conditions such as otitis media and bronchitis. Accurate and rapid laboratory identification of H. influenzae is critical for effective patient management, but its close morphological and genetic relationship with other Haemophilus species, such as the nonpathogenic Haemophilus haemolyticus, necessitates a panel of specific tests. The primary diagnostic approach combines the assessment of unique growth requirements with a set of classical biochemical reactions, which not only confirm the species but also subdivide it into clinically relevant biotypes. These biochemical tests are indispensable tools in the clinical microbiology laboratory for making a definitive identification and providing important epidemiological data.
Essential Growth Factor Requirements (X and V Factors)
A cornerstone of *Haemophilus* species identification is the determination of their nutritional growth requirements, specifically for X-factor (Hemin) and V-factor (Nicotinamide Adenine Dinucleotide or NAD). *H. influenzae* is a parasitic organism of the respiratory tract membrane and is incapable of synthesizing the heme component of cytochromes and other iron-containing porphyrins. Therefore, it requires both the X-factor and the V-factor for in vitro growth, making it a fastidious microorganism. This requirement is typically assessed by inoculating the organism onto Mueller Hinton agar plates and placing commercially available discs containing X-factor, V-factor, and a combination of both (XV-factor) onto the surface. Growth solely around the XV-factor disc confirms its dual factor dependence. The reliance on these factors is also the principle behind the ‘satellitism’ phenomenon, where *H. influenzae* colonies grow near colonies of other bacteria (like *Staphylococcus aureus*) that produce and secrete the V-factor into the medium. On Sheep Blood Agar, the V-factor is sequestered inside red blood cells, which is why *H. influenzae* is typically grown on Chocolate Agar, where heat lysis of red blood cells releases the necessary V-factor.
The Three Key Biochemical Tests for Biotyping
While the X and V factor test confirms the genus and species, *H. influenzae* isolates are further categorized into eight biotypes (I through VIII) based on the results of three key enzymatic tests: Indole production, Urease activity, and Ornithine Decarboxylase (ODC) activity. These biotypes often show a correlation with the organism’s site of colonization, association with specific types of infection, and even antimicrobial resistance profiles, highlighting their clinical and epidemiological significance. The conventional methods for these tests, along with various commercial rapid test systems, are used for this essential subtyping. Other general enzymatic tests also contribute to the overall biochemical profile: *H. influenzae* is consistently positive for Catalase and Oxidase, and is a Nitrate Reducer, but is non-motile, does not produce H2S, and is negative for fermentation of adonitol, arabinose, cellobiose, and dulcitol.
The Indole Production Test
The Indole test assesses the bacterium’s ability to produce the enzyme tryptophanase, which hydrolyzes the amino acid tryptophan into three products: indole, pyruvic acid, and ammonia. To perform the test, the organism is grown in a medium rich in tryptophan. Following incubation, Kovacs’ or Ehrlich’s reagent is added. If indole is present (a positive result), it reacts with the aldehyde in the reagent to form a characteristic red ring on the surface of the medium or in the solvent layer. Indole production is one of the three differential tests used in the biotyping scheme for *H. influenzae*. The result is noted as either positive or negative, though a variable reaction has been observed in some strains. For example, Biotypes I and III are positive for indole, while Biotypes II and IV are negative, serving as a simple differentiator.
The Urease Activity Test
The Urease test determines whether the organism can produce the enzyme urease, which hydrolyzes urea into ammonia and carbon dioxide. This reaction significantly increases the alkalinity of the test medium, typically detected by a pH indicator such as phenol red. The test is typically performed by inoculating a urea broth or slant. A positive Urease test is indicated by a color change from yellow (acidic) to pink or red (alkaline). This enzyme activity is essential for classifying the biotype, as a positive reaction in this test is key to distinguishing certain biotypes from others in the classification scheme. For instance, the enzyme’s presence is used to differentiate Biotypes I, II, III, and IV, where Urease activity is positive, from Biotypes V, VI, VII, and VIII, which are Urease negative. This differentiation provides a clear separation of isolates into two major biotype groups.
The Ornithine Decarboxylase (ODC) Test
The Ornithine Decarboxylase (ODC) test determines the presence of the enzyme ornithine decarboxylase, which acts to decarboxylate the amino acid L-ornithine, converting it into the polyamine putrescine. This process consumes the carboxyl group, which raises the pH of the medium. The test is performed in a decarboxylase base medium containing L-ornithine and a pH indicator (like bromocresol purple or cresol red). The medium is initially acidic due to the incorporation of glucose. If ODC is produced (a positive result), the resulting putrescine causes a shift back to an alkaline pH, indicated by a color change from yellow back to purple or red. This test is the third critical component in the standard *H. influenzae* biotyping scheme, with variability in its results across different biotypes. When commercial kits are used, ODC results have sometimes been challenging, with some systems yielding false-positive ODC results for Biotype II and III strains, making it necessary to perform conventional ODC tests to establish a definitive biotype in the case of a discrepancy. The ODC result, in combination with Indole and Urease, completes the eight-biotype profile.
The Biotype Classification System and Clinical Utility
The combination of results from the Indole (I), Urease (U), and Ornithine Decarboxylase (O) tests forms the basis of the biotype classification for *H. influenzae* and *H. parainfluenzae*. An I+/U+/O+ profile, for example, corresponds to Biotype I, while an I-/U+/O+ profile is Biotype II. This eight-group classification, established by Killian, is not arbitrary. It is clinically significant because certain biotypes have been historically linked to specific disease syndromes. For instance, Biotype I strains were often associated with invasive disease. Although serotyping (capsular type a-f) remains the primary determinant of virulence, particularly for the highly invasive Type b (Hib), biotyping is a valuable tool for epidemiological tracking, outbreak investigation, and understanding the general biological characteristics of isolates recovered from both sterile and non-sterile sites. The biotype provides an additional level of characterization beyond species identification.
Commercial and Advanced Identification Methods
For rapid identification and biotyping, clinical laboratories rely on various commercial kits. Systems like the API NH strip, the Neisseria-Haemophilus identification test (NHI card), and the IDS RapID NH system automate or miniaturize the conventional biochemical reactions. Comparative studies have shown that the accuracy of these systems for biotyping can vary; for instance, the API NH strip has historically performed well, correctly classifying over 97% of challenge strains, while other kits have been less reliable, particularly with the ODC reaction. More recently, Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) has emerged as a first-line routine-compatible option for rapid species identification due to its high sensitivity and specificity. However, even with MALDI-TOF, discrimination from closely related nonpathogenic species like *H. haemolyticus* can be difficult due to small spectral differences. Therefore, the combination of biochemical testing, especially for biotyping, with newer molecular or mass spectrometry techniques provides the most comprehensive and robust identification of *H. influenzae* in the modern clinical setting, ensuring accurate diagnosis and appropriate treatment.